ArticleThe Journal of nutrition2025
Placental Metabolism Is Linked to Prenatal Vitamin Supplement Use in the First Month of Pregnancy in the MARBLES Cohort.
Article in The Journal of nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe first month of pregnancy is a key time in early developmental programming. Prenatal vitamin/mineral supplement use during the first month of pregnancy (PNVmo1) was associated with reduced risk of autism spectrum disorder (ASD) in the Markers of Autism Risk in Babies, Learning Early Signs (MARBLES) cohort.
objectivesWe aimed to evaluate the associations between PNVmo1, the placental and umbilical cord serum metabolomes, and the child's later neurodevelopmental outcome in the MARBLES pregnancy cohort.
methodsPlacental (n = 78) and umbilical cord serum (n = 132) metabolomes were investigated using
resultsAfter adjustment for covariates, permutational multivariate analysis of variance revealed that PNVmo1 was significantly (P < 0.05) associated with the placental and umbilical cord serum metabolomes. In the placenta, higher concentrations of amino acids were observed in the PNVmo1 group (false discovery rate <0.1). After adjustment for PNVmo1 and other covariates, permutational multivariate analysis of variance revealed a significant association (P < 0.05) between the placental metabolome and Non-TD outcome status. No associations were observed in the analyses of umbilical cord serum metabolism or with ASD outcome. We tested for but did not find evidence that the placental metabolome explained the relationship between PNVmo1 and Non-TD outcome in an exploratory mediation analysis.
conclusionsThese findings suggest that the placental metabolome could be sensitive to nutrient supplementation during the earliest stages of pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.